{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,29]],"date-time":"2026-10-29T20:33:02Z","timestamp":1793305982581,"version":"4.5.0"},"reference-count":35,"publisher":"Elsevier BV","issue":"12","license":[{"start":{"date-parts":[[2026,12,1]],"date-time":"2026-12-01T00:00:00Z","timestamp":1796083200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,12,1]],"date-time":"2026-12-01T00:00:00Z","timestamp":1796083200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/501100003625","name":"Korea Ministry of Health and Welfare","doi-asserted-by":"publisher","award":["RS-2025-02220492"],"award-info":[{"award-number":["RS-2025-02220492"]}],"id":[{"id":"10.13039\/501100003625","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100014188","name":"Ministry of Science and ICT, South Korea","doi-asserted-by":"publisher","award":["IITP-2026-RS-2024-00438239"],"award-info":[{"award-number":["IITP-2026-RS-2024-00438239"]}],"id":[{"id":"10.13039\/501100014188","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100014188","name":"Ministry of Science and ICT, South Korea","doi-asserted-by":"publisher","award":["IITP-2026-RS-2026-25617111"],"award-info":[{"award-number":["IITP-2026-RS-2026-25617111"]}],"id":[{"id":"10.13039\/501100014188","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["International Journal of Antimicrobial Agents"],"published-print":{"date-parts":[[2026,12]]},"DOI":"10.1016\/j.ijantimicag.2026.108013","type":"journal-article","created":{"date-parts":[[2026,9,22]],"date-time":"2026-09-22T17:26:21Z","timestamp":1790097981000},"page":"108013","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["Pharmacovigilance signals and regional burden of antibiotic-associated Clostridioides difficile infection: A pharmacovigilance study and Global Burden of Disease Study 2023"],"prefix":"10.1016","volume":"67","author":[{"given":"Dain Y.","family":"Kim","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hyunjeong","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hyunyi","family":"Yoo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hyoin","family":"Shin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0241-8772","authenticated-orcid":false,"given":"Hyunju","family":"Yon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Taelim","family":"Choi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Junmo","family":"Moon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hyunjee","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jos\u00e9 Francisco","family":"L\u00f3pez-Gil","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Masoud","family":"Rahmati","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Selin","family":"Woo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0005-2009-386X","authenticated-orcid":false,"given":"Jaeyu","family":"Park","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1628-9948","authenticated-orcid":false,"given":"Dong Keon","family":"Yon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ijantimicag.2026.108013_bib0001","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1038\/s41579-025-01242-2","article-title":"Clostridioides difficile pathogenesis and control","volume":"24","author":"Chilton","year":"2026","journal-title":"Nat Rev Microbiol"},{"key":"10.1016\/j.ijantimicag.2026.108013_bib0002","doi-asserted-by":"crossref","first-page":"1320","DOI":"10.1056\/NEJMoa1910215","article-title":"Trends in U.S. burden of Clostridioides difficile infection and outcomes","volume":"382","author":"Guh","year":"2020","journal-title":"N Engl J Med"},{"key":"10.1016\/j.ijantimicag.2026.108013_bib0003","doi-asserted-by":"crossref","DOI":"10.1080\/07853890.2025.2451762","article-title":"Global burden and trends of the Clostridioides difficile infection-associated diseases from 1990 to 2021: an observational trend study","volume":"57","author":"Xia","year":"2025","journal-title":"Ann Med"},{"key":"10.1016\/j.ijantimicag.2026.108013_bib0004","doi-asserted-by":"crossref","DOI":"10.1001\/jamanetworkopen.2025.25252","article-title":"Antibiotic use and the risk of hospital-onset Clostridioides difficile infection","volume":"8","author":"Gilboa","year":"2025","journal-title":"JAMA Netw Open"},{"key":"10.1016\/j.ijantimicag.2026.108013_bib0005","doi-asserted-by":"crossref","DOI":"10.1073\/pnas.2411919121","article-title":"Global trends in antibiotic consumption during 2016-2023 and future projections through 2030","volume":"121","author":"Klein","year":"2024","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1016\/j.ijantimicag.2026.108013_bib0006","doi-asserted-by":"crossref","first-page":"836","DOI":"10.1093\/cid\/ciaa124","article-title":"Antibiotic prescribing choices and their comparative C. difficile infection risks: a longitudinal case-cohort study","volume":"72","author":"Brown","year":"2021","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.ijantimicag.2026.108013_bib0007","doi-asserted-by":"crossref","DOI":"10.7189\/jogh.14.04135","article-title":"The global burden and trend of Clostridioides difficile and its association with world antibiotic consumption, 1990-2019","volume":"14","author":"Chen","year":"2024","journal-title":"J Glob Health"},{"key":"10.1016\/j.ijantimicag.2026.108013_bib0008","doi-asserted-by":"crossref","first-page":"2526","DOI":"10.1038\/s41591-023-02549-4","article-title":"Longitudinal genomic surveillance of carriage and transmission of Clostridioides difficile in an intensive care unit","volume":"29","author":"Miles-Jay","year":"2023","journal-title":"Nat Med"},{"key":"10.1016\/j.ijantimicag.2026.108013_bib0009","doi-asserted-by":"crossref","DOI":"10.1136\/bmjgh-2021-008181","article-title":"A \u2018whole of United Nations approach\u2019 to tackle antimicrobial resistance? A mapping of the mandate and activities of international organisations","volume":"7","author":"Wernli","year":"2022","journal-title":"BMJ Glob Health"},{"key":"10.1016\/j.ijantimicag.2026.108013_bib0010","doi-asserted-by":"crossref","first-page":"S3","DOI":"10.1097\/INF.0000000000003318","article-title":"Comparison of antimicrobial stewardship and infection prevention and control activities and resources between low-\/middle- and high-income countries","volume":"41","author":"Villanueva","year":"2022","journal-title":"Pediatr Infect Dis J"},{"key":"10.1016\/j.ijantimicag.2026.108013_bib0011","doi-asserted-by":"crossref","DOI":"10.1016\/j.lanhl.2024.100648","article-title":"Early geriatric assessment and management in older patients with Clostridioides difficile infection in Denmark (CLODIfrail): a randomised trial","volume":"5","author":"Rubak","year":"2024","journal-title":"Lancet Healthy Longev"},{"key":"10.1016\/j.ijantimicag.2026.108013_bib0012","doi-asserted-by":"crossref","first-page":"1873","DOI":"10.1016\/S0140-6736(25)01637-X","volume":"406","author":"Hay","year":"2025","journal-title":"Lancet"},{"key":"10.1016\/j.ijantimicag.2026.108013_bib0013","doi-asserted-by":"crossref","first-page":"1811","DOI":"10.1016\/S0140-6736(25)01917-8","article-title":"Global burden of 292 causes of death in 204 countries and territories and 660 subnational locations, 1990-2023: a systematic analysis for the Global Burden of Disease Study 2023","volume":"406","author":"Naghavi","year":"2025","journal-title":"Lancet"},{"key":"10.1016\/j.ijantimicag.2026.108013_bib0014","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1186\/s13058-025-02013-w","article-title":"Pharmacovigilance study of adverse reactions of anti-HER-2 drugs for the treatment of HER-2-positive breast cancer based on the FAERS database","volume":"27","author":"Han","year":"2025","journal-title":"Breast Cancer Res"},{"key":"10.1016\/j.ijantimicag.2026.108013_bib0015","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1007\/s40801-021-00268-1","article-title":"Delirium Associations with antibiotics: a pharmacovigilance study of the FDA Adverse Event Reporting System (FAERS)","volume":"9","author":"Teng","year":"2022","journal-title":"Drugs Real World Outcomes"},{"key":"10.1016\/j.ijantimicag.2026.108013_bib0016","doi-asserted-by":"crossref","DOI":"10.1177\/20420986251401122","article-title":"Cardiotoxicity associated with antineoplastic agents: a pharmacovigilance study based on FDA adverse event reporting system","volume":"16","author":"Qiu","year":"2025","journal-title":"Ther Adv Drug Saf"},{"key":"10.1016\/j.ijantimicag.2026.108013_bib0017","doi-asserted-by":"crossref","first-page":"S194","DOI":"10.1093\/infdis\/jiaa408","article-title":"Mechanisms of colonization resistance against Clostridioides difficile","volume":"223","author":"Pike","year":"2021","journal-title":"J Infect Dis"},{"key":"10.1016\/j.ijantimicag.2026.108013_bib0018","doi-asserted-by":"crossref","first-page":"820","DOI":"10.1016\/j.chom.2024.05.002","article-title":"Intestinal colonization resistance in the context of environmental, host, and microbial determinants","volume":"32","author":"Woelfel","year":"2024","journal-title":"Cell Host Microbe"},{"key":"10.1016\/j.ijantimicag.2026.108013_bib0019","doi-asserted-by":"crossref","first-page":"ofad413","DOI":"10.1093\/ofid\/ofad413","article-title":"Comparison of different antibiotics and the risk for community-associated Clostridioides difficile infection: a case-control study","volume":"10","author":"Miller","year":"2023","journal-title":"Open Forum Infect Dis"},{"key":"10.1016\/j.ijantimicag.2026.108013_bib0020","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1186\/s40001-023-01432-9","article-title":"Interaction of Clostridioides difficile infection with frailty and cognition in the elderly: a narrative review","volume":"28","author":"Fernandez-Cotarelo","year":"2023","journal-title":"Eur J Med Res"},{"key":"10.1016\/j.ijantimicag.2026.108013_bib0021","doi-asserted-by":"crossref","first-page":"755","DOI":"10.1093\/cid\/ciab718","article-title":"Clinical practice Guideline by the Infectious Diseases Society of America (IDSA) and Society for Healthcare Epidemiology of America (SHEA): 2021 focused update guidelines on management of Clostridioides difficile infection in adults","volume":"73","author":"Johnson","year":"2021","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.ijantimicag.2026.108013_bib0022","doi-asserted-by":"crossref","first-page":"1407","DOI":"10.1016\/j.jiac.2021.05.010","article-title":"Retrospective study of the efficacy and safety of metronidazole and vancomycin for Clostridioides difficile infection","volume":"27","author":"Misawa","year":"2021","journal-title":"J Infect Chemother"},{"key":"10.1016\/j.ijantimicag.2026.108013_bib0023","doi-asserted-by":"crossref","DOI":"10.1128\/AAC.02169-19","article-title":"Antibiotic exposure and risk for hospital-associated Clostridioides difficile infection","volume":"64","author":"Webb","year":"2020","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.ijantimicag.2026.108013_bib0024","doi-asserted-by":"crossref","DOI":"10.1542\/peds.2023-062307","article-title":"Clostridioides difficile infection in children: recent updates on epidemiology, diagnosis, therapy","volume":"152","author":"Shirley","year":"2023","journal-title":"Pediatrics"},{"key":"10.1016\/j.ijantimicag.2026.108013_bib0025","doi-asserted-by":"crossref","first-page":"997","DOI":"10.1017\/ice.2019.160","article-title":"Incidence of Clostridioides difficile infections among young and middle-aged adults: veterans health administration","volume":"40","author":"Russo","year":"2019","journal-title":"Infect Control Hosp Epidemiol"},{"key":"10.1016\/j.ijantimicag.2026.108013_bib0026","doi-asserted-by":"crossref","DOI":"10.1016\/j.anaerobe.2022.102540","article-title":"A narrative review of Clostridioides difficile infection in China","volume":"74","author":"Wu","year":"2022","journal-title":"Anaerobe"},{"key":"10.1016\/j.ijantimicag.2026.108013_bib0027","article-title":"Incidence of Clostridioides difficile infections in Republic of Korea: a prospective study with active surveillance vs. national data from Health Insurance Review & Assessment Service","volume":"39","author":"Kim","year":"2024","journal-title":"J Korean Med Sci"},{"key":"10.1016\/j.ijantimicag.2026.108013_bib0028","doi-asserted-by":"crossref","first-page":"651.e1","DOI":"10.1016\/j.cmi.2022.12.019","article-title":"Clostridioides difficile infection (CDI): a pan-European multi-center cost and resource utilization study, results from the Combatting Bacterial Resistance in Europe CDI (COMBACTE-CDI)","volume":"29","author":"Wingen-Heimann","year":"2023","journal-title":"Clin Microbiol Infect"},{"key":"10.1016\/j.ijantimicag.2026.108013_bib0029","doi-asserted-by":"crossref","DOI":"10.1016\/j.anaerobe.2022.102549","article-title":"Clostridioides difficile infection in Africa: a narrative review","volume":"74","author":"Kullin","year":"2022","journal-title":"Anaerobe"},{"key":"10.1016\/j.ijantimicag.2026.108013_bib0030","doi-asserted-by":"crossref","DOI":"10.1016\/j.anaerobe.2024.102821","article-title":"The burden of Clostridioides difficile infections in South-East Asia and the Western Pacific: a narrative review","volume":"86","author":"Angulo","year":"2024","journal-title":"Anaerobe"},{"key":"10.1016\/j.ijantimicag.2026.108013_bib0031","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1016\/j.jamda.2019.11.010","article-title":"Reducing fluoroquinolone use and Clostridioides difficile infections in community nursing homes through hospital-nursing home collaboration","volume":"21","author":"Felsen","year":"2020","journal-title":"J Am Med Dir Assoc"},{"key":"10.1016\/j.ijantimicag.2026.108013_bib0032","article-title":"Antibiotics associated with Clostridium difficile infection","volume":"15","author":"Rafey","year":"2023","journal-title":"Cureus"},{"key":"10.1016\/j.ijantimicag.2026.108013_bib0033","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1016\/j.jhin.2025.04.039","article-title":"Identifying indicators and targets for the new World Health Organization Global Framework on Infection Prevention and Control: an e-Delphi study","volume":"165","author":"Satta","year":"2025","journal-title":"J Hosp Infect"},{"key":"10.1016\/j.ijantimicag.2026.108013_bib0034","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1159\/000535851","article-title":"Microbiota-based therapeutics as new standard-of-care treatment for recurrent Clostridioides difficile infection","volume":"40","author":"Stallhofer","year":"2024","journal-title":"Visc Med"},{"key":"10.1016\/j.ijantimicag.2026.108013_bib0035","doi-asserted-by":"crossref","first-page":"527","DOI":"10.1017\/ice.2023.18","article-title":"Strategies to prevent Clostridioides difficile infections in acute-care hospitals: 2022 update","volume":"44","author":"Kociolek","year":"2023","journal-title":"Infect Control Hosp Epidemiol"}],"container-title":["International Journal of Antimicrobial Agents"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0924857926003006?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0924857926003006?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,10,29]],"date-time":"2026-10-29T20:21:22Z","timestamp":1793305282000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0924857926003006"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,12]]},"references-count":35,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2026,12]]}},"alternative-id":["S0924857926003006"],"URL":"https:\/\/doi.org\/10.1016\/j.ijantimicag.2026.108013","relation":{},"ISSN":["0924-8579"],"issn-type":[{"value":"0924-8579","type":"print"}],"subject":[],"published":{"date-parts":[[2026,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Pharmacovigilance signals and regional burden of antibiotic-associated Clostridioides difficile infection: A pharmacovigilance study and Global Burden of Disease Study 2023","name":"articletitle","label":"Article Title"},{"value":"International Journal of Antimicrobial Agents","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ijantimicag.2026.108013","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Elsevier Ltd and International Society of Antimicrobial Chemotherapy. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"108013"}}